8,649
Total Claims
$1.3M
Drug Cost
539
Beneficiaries
$2,471
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-72%
Opioid rate vs peers
0.6% vs 2.2% avg
+75%
Cost per patient vs peers
$2,471 vs $1,411 avg
+85%
Brand preference vs peers
19.7% vs 10.6% avg
Opioid Prescribing
0.6%
Opioid Rate
54
Opioid Claims
$391
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
80% generic
Brand: 1,678 claims · $1.2M
Generic: 6,859 claims · $173K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 177 | $210K |
| Dulaglutide | 106 | $128K |
| Apixaban | 134 | $116K |
| Semaglutide | 78 | $83K |
| Semaglutide | 49 | $66K |
| Sacubitril/Valsartan | 47 | $58K |
| Fluticasone Propion/Salmeterol | 79 | $40K |
| Fluticasone/Umeclidin/Vilanter | 51 | $40K |
| Rivaroxaban | 42 | $33K |
| Tiotropium Bromide | 51 | $31K |
| Insulin Glargine,hum.Rec.Anlog | 66 | $30K |
| Linagliptin | 43 | $29K |
| Atorvastatin Calcium | 821 | $19K |
| Fluticasone Propion/Salmeterol | 29 | $18K |
| Tirzepatide | 16 | $17K |
Prescribing Profile
Patient Profile
67
Avg Age
57%
Female
1.68
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data